We evaluated the results of endovascular management of patients with mid-basilar artery aneurysm (mBAA).
Introduction
Aneurysms of the mid-basilar artery (mBA) are rare and these aneurysms have a poorer prognosis [1] [2] [3] [4] [5] . Higa et al. documented a five year incidence of severe morbidity and mortality of 80% 2 . Anatomically, the basilar artery (BA) is located in the depth of the valley surrounded by the bilateral petrous bones. Surgical access to this area is hampered by a dense collection of vital cranial nerves and perforating arteries to the brain stem 6, 7 . Challenges include difficulty with the surgical approach; the frequent occurrence of broad-necked, fusiform or giant aneurysms; and the incorporation of the branches of BA. As a result, the rarity and unique morphological features of mBAAs make it difficult to individually tailor the treatment strategy 2, 5 . However, an endovascular approach to this area is comparatively easy because of the simple access to the BA 4, [8] [9] [10] [11] [12] [13] [14] [15] [16] . The aim of this retrospective analysis was evaluation of endovascular management for mBAAs.
Clinical Material and Methods
Sixty-two patients with basilar artery aneurysms underwent endovascular treatment at our institute between 2000 and 2007. Fourteen patients (22.6%) had mid-basilar artery aneurysms, which were included in this study. There were seven women (50%) and seven men (50%), ranging from 18 to 68 years with a mean age of 39.6 years. Ten patients (71.4%) presented with SAH and four patients (28.6%) presenting without SAH had headaches. Based on the Hunt and Hess grading scale, six patients (60%) were Grade I, one (10%) was Grade II and three (30%) were Grade III.
All procedures were performed or supervised by the senior author (ZW). All endovas-cular procedures were performed via the transfemoral arterial route. All endovascular surgeries were performed under general anesthesia. All the procedures were performed under full systemic heparinization to maintain the activated clotting time around twice the base value. In this series, Guglielmi detachable coils (GDC, Boston Scientific, Fremont, CA, USA/Orbit, Cordis, CA, USA/Microvention, Microvention, Aliso Vajo, USA) were mainly used to fill the aneurysm. The detachable coils were delivered under road-mapping guidance, and the aneurysm was packed as densely as possible. One patient underwent endovascular parent vessel occlusions without bypass procedure. If a stent was placed, the patient was medicated with 300 mg/d aspirin and 75 mg/d clopidogrel three days before the procedure and with 300 mg/d aspirin for a month afterwards.
Postoperative angiography was classified as follows: complete occlusion, subtotal, or incomplete. Results of follow-up angiography were also classified in the same way, and clinical outcomes were evaluated according to Glasgow Outcome Scale scores.
Results
The aneurysms were small in seven (diameter <10 mm), large in five (10 to 25 mm), and giant in three (>25 mm). Four (26.7%) aneurysms were saccular, nine (60%) were acute dissecting aneurysms and two (13.3%) were arteriosclerotic aneurysms. One case was associated with two aneurysms. All cases are shown in Table 1 . Nine stents (two Driver stents, one Neuroform stent, five Leo stents and one Enterprise stent) were used in nine cases. In ten (66.7%) of the 15 mBAAs, complete occlusion was achieved, while subtotal occlusion was found in one (6.7%), and incomplete occlusion in four (26.6%). Neurological status worsened in one (7.1%) out of 14 cases, resulting in left limb weakness after treatment. Follow-up angiography was obtained in ten surviving cases at 6.8 months (range, three to 12 months) after treatment and there was complete occlusion in all aneurysms.
After a mean follow-up duration of 15.6 months (range, three to 70 months), outcome in ten patients (71.4%) was reflected by a GOS score of 4 or 5, in four (28.6%) by a score of 1.
Recurrent SAH was confirmed to be the cause of death in four patients (occurring after endovascular treatment), two were stented only, one was partially coiled and one was completely coiled.
Discussion
Mid-basilar artery aneurysms comprise 22.6% of basilar artery aneurysms. These aneurysms have a poorer prognosis than aneurysms at other locations because of their dis- secting nature, as in our cases 5 . The most common finding in our series was a pseudoaneurysm with irregular vessel lumen narrowing proximally.
Patients with lesions involving the basilar artery trunk without adequate collateral circu-lation from the posterior communicating arteries are at highest risk 10 . Higa et al. documented a five year incidence of severe morbidity and a mortality of 80% 2 . Several neurosurgical approaches have been used to access the basilar artery as described by many au- thors, but these approaches have been successful only in the hands of a limited number of skilled neurosurgeons 6, 7 . On the other hand, endovascular access to the BA is not difficult in general 4, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Since then, we have selected endovascular surgery as the first choice of treatment for mBAAs with anticipated surgical difficulties. Three cases of basilar trunk endovascular occlusion have been reported in cases of giant and fusiform aneurysms of the BA with good outcome 16 . We present one patient with an upper BA fusiform aneurysm treated successfully with endovascular occlusion of the aneurysm and basilar trunk. In determining the safety of BA occlusion, the most important factor to be taken into account is the presence and size of the PCoAs 16, 18, 19 . Therefore, before occlusion of the BA during therapy is considered, documentation of the presence and size of the PCoAs is essential. The presence of an adequate caliber of posterior communicating artery allowed retrograde filling of the BA. In a series of vertebrobasilar aneurysms treated by parent vessel occlusion, delayed neurological complications were reported in 45% of the cases and the majority of these complications were found to be fatal 10, 16, 18 . The immediate risk of endovascular treatment needs to be weighted against the predicted annual likelihood of morbidity and mortality from this disease, in patients with risk factors commonly seen in the stroke population.
Typically acute dissecting aneurysms are associated with proximal and distal narrowing of the lumen representing evidence of extension of the dissecting process along the wall. Arteriosclerotic, saccular aneurysms do not have this up and downstream luminal narrowing and the widening represents the diseased segment of the vessel. This is a very important differentiation point and the reason why dissecting aneurysms treated by luminal coiling tend to rebleed because the dissecting process spreads along the wall and may be responsible for rerupture, hence parent vessel occlusion or reconstruction with stent placement along the entire length of the involved vessel segment is needed for protection. Stent placement has the advantage of allowing the maintenance of the parent arterial lumen [20] [21] [22] [23] [24] [25] [26] [27] [28] . Endovascular stenting without coiling has been used successfully for the treatment of atherosclerotic lesions, pseudo-aneurysms, fusiform aneurysms, arterial dissections and thrombosis of the cerebral vasculature as reported by multiple authors 14 . Park et al. described patients with fusiform and dissecting aneurysms in whom endovascular stenting alone, without coiling, lead to aneurysm thrombosis 14 . However, our our patients with giant BA trunk aneurysms treated with stenting alone died of rebleeding within one month after the procedure.
Although detachable coils have provided an alternative approach to treatment, they have their own difficulties in the treatment of giant and fusiform aneurysms of the BA 1, 10, 16, 18 . Clot formation in the sac does not mean the aneurysm is completely cured. Subsequent bleeding was observed in four patients, two giant aneurysms were treated with stenting without coiling and two was coiled completely on angiogram. The rebleeding rate of coil embolization in this series was 28.6%.
Reported results for BA and VBJ aneurysms were less favorable with a good outcome (GOS 4-5 ) in 39% and death in 44% 1, 7, 10, 14, 16 . Yoshimoto et al. reported favorable outcomes in four (40%) out of ten patients with BA fusiform aneurysms, of whom four presented with SAH 5 . Two of the four patients who presented with SAH underwent endovascular treatment. One of the two patients died and the other had a good recovery. In our present series, ten fared well at long-term follow up, and four deaths were caused by SAH within one day after endovascular treatment. It seems that giant size and stent treatment alone present a likelihood of post-embolization rebleeding.
Conclusions
The natural history of mBAAs is dismal. Technical advances and growing experience with endovascular techniques have resulted in an increased percentage of patients undergoing endovascular therapies. Favorable overall longterm outcome can be achieved in 71.4% patients with mBAAs.
